Back to results
US 2021/0341487 A1Published application
Neutralizing antibody assay for therapeutic proteins
AssigneeRegeneron Pharmaceuticals, Inc.
InventorsMichael Partridge, Susan Irvin, Manoj Rajadhyaksha, Aynur Hermann
Life of this patent
Estimating the term…
Abstract
The present invention generally pertains to methods of testing for the presence of neutralizing antibodies (NAbs) against therapeutic proteins. In particular, the present invention pertains to the use of mitigating agents against interfering competing drugs in ligand binding assays or cell-based assays for the detection of neutralizing antibodies against therapeutic proteins.
Claims39
A method for detecting a neutralizing agent to a therapeutic protein in a sample, comprising:
- (a) contacting said sample having said neutralizing agent and a competing drug to said therapeutic protein, a target of said therapeutic protein, and a mitigating agent;
- (b) measuring a binding of said therapeutic protein to said target;
- and
- (c) comparing the result of (b) to a control measurement to detect said neutralizing agent.
1 more element
A kit, comprising:
- (a) a therapeutic protein;
- (b) a target of said therapeutic protein;
- (c) a neutralizing agent against said therapeutic protein;
- (d) a competing drug;
- and
- (e) a mitigating agent.
3 more elements
Dependencies are inferred from the claim text.